The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Stefano De Servi

Showing 1-11 of 11 articles
Low-dose prasugrel versus clopidogrel in elderly patients with high clinical and PCI complexity
Montalto C, Crimi G, Savonitto S, De Servi S
August 7, 2020 | 10.4244/EIJ-D-19-00859
Impact of sex on comparative outcomes of bivalirudin versus unfractionated heparin in patients with acute coronary syndromes undergoing invasive management: a pre-specified analysis of the MATRIX trial
Gargiulo G, Pasquetto G, Brugaletta S, Ferrari F, Casu G, Guiducci V, Dellavalle A, Liistro F, Mauro C, van't Hof A, Omerovic E, Curello S, de la Torre Hernandez J, De Servi S, Belloni F, Windecker S, Penzo C, Colombo A, da Costa B, Frigoli E, Palmieri C, Nazzaro M, Falcone C, Liso A, Vigna C, Abate F, Comeglio M, Diletti R, Gabrielli G, Di Lorenzo E, Mazzarotto P, Zimarino M, Moretti C, Valgimigli M
June 12, 2019 | 10.4244/EIJ-D-18-00247
Coronary interventions
Incidence and outcome of switching of oral platelet P2Y12 receptor inhibitors in patients with acute coronary syndromes undergoing percutaneous coronary intervention: the SCOPE registry
De Luca L, D’ascenzo F, Musumeci G, Saia F, Parodi G, Varbella F, Marchese A, De Servi S, Berti S, Bolognese L
July 20, 2017 | 10.4244/EIJ-D-17-00092
Coronary interventions
Relationship between diabetes, platelet reactivity, and the SYNTAX score to one-year clinical outcome in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention
De Servi S, Crimi G, Calabrò P, Piscione F, Cattaneo M, Maffeo D, Toso A, Bartorelli A, Palmieri C, De Carlo M, Capodanno D, Barozzi C, Tomasi L, Della Riva D, Angiolillo D, Palmerini T
June 20, 2016 | 10.4244/EIJV12I3A51
Cystatin C and risk of mortality among patients undergoing percutaneous coronary intervention
Angeli F, Verdecchia P, Savonitto S, Arraiz G, Zaninotto M, Broccatelli A, Cosma C, De Servi S, Sabino F, Briguori C, Ambrosio G, Cavallini C
November 20, 2015 | 10.4244/EIJY14M08_02
CoreValve implantation for severe aortic regurgitation: a multicentre registry
Testa L, Latib A, Rossi M, De Marco F, De Carlo M, Fiorina C, Oreglia J, Petronio A, Ettori F, De Servi S, Klugmann S, Ussia G, Tamburino C, Panisi P, Brambilla N, Colombo A, Presbitero P, Bedogni F
October 20, 2014 | 10.4244/EIJV10I6A127
Perioperative management of antiplatelet therapy in patients with coronary stents undergoing cardiac and non-cardiac surgery: a consensus document from Italian cardiological, surgical and anaesthesiological societies
Rossini R, Musumeci G, Visconti L, Bramucci E, Castiglioni B, De Servi S, Lettieri C, Lettino M, Piccaluga E, Savonitto S, Trabattoni D, Capodanno D, Buffoli F, Parolari A, Dionigi G, Boni L, Biglioli F, Valdatta L, Droghetti A, Bozzani A, Setacci C, Ravelli P, Crescini C, Staurenghi G, Pietro Scarone P, Francetti L, D’Angelo F, Gadda F, Comel A, Salvi L, Lorini L, Antonelli M, Bovenzi F, Cremonesi A, Angiolillo D, Guagliumi G
May 20, 2014 | 10.4244/EIJV10I1A8
Simplifying clinical risk prediction for percutaneous coronary intervention of bifurcation lesions: the case for the ACEF (age, creatinine, ejection fraction) score
Biondi-Zoccai G, Romagnoli E, Castagno D, Sheiban I, De Servi S, Tamburino C, Colombo A, Burzotta F, Presbitero P, Bolognese L, Paloscia L, Rubino P, Sardella G, Briguori C, Niccoli L, Franco G, Di Girolamo D, Piatti L, Greco C, Petronio A, Loi B, Benassi A, Patti A, Gaspardone A, Frati G, Sangiorgi G
July 27, 2012 | 10.4244/EIJV8I3A55
Safety and efficacy of biodegradable vs. durable polymer drug-eluting stents: evidence from a meta-analysis of randomised trials
Navarese E, Kubica J, Castriota F, Gibson M, De Luca G, Buffon A, Bolognese L, Margheri M, Andreotti F, Di Mario C, De Servi S
December 30, 2011 | 10.4244/EIJV7I8A155
Sex-related differences in patients undergoing percutaneous unprotected left main stenting
Sheiban I, La Spina C, Cavallero E, Biondi-Zoccai G, Colombo F, Palmerini T, Marzocchi A, Tamburino C, Margheri M, Vecchi G, Sangiorgi G, Santarelli A, Bartorelli A, Briguori C, Vignali L, di Pede F, Ramondo A, Fantoni C, De Carlo M, Falsini G, Benassi A, Palmieri C, Filippone V, Sangiorgi D, De Servi S
February 25, 2010
Diabetic patients treated for unprotected left main coronary artery disease with drug eluting stents: a 3-year clinical outcome study. The Diabetes and Drug Eluting stent for LeFT main registry (D-DELFT)
Meliga E, Garcia-Garcia H, Valgimigli M, Chieffo A, Biondi-Zoccai G, O’ Maree A, Gonzalo N, Cook S, Cruz-Gonzalez I, Marra S, De Servi S, Palacios I, Windecker S, van Domburg R, Colombo A, Sheiban I, Serruys P
May 13, 2008

Latest news

NEW ISSUE
Focus on emerging physiology indices, TAVI, sizing with abnormal aortic cusps, a megaregistry of complex PCIs and more…
Tetralogy of Fallot with acquired double right ventricular outflow tract
September 18, 2020
NEW
Ahead of print: Leaflex Study
September 23, 2020
Editorial
Integrating physiology in OCT
Gianluca Campo
September 23, 2020
PCR Trials
BioFlow IV, TWILIGHT, Evolut Low Risk and many others
(Released thanks to the support of Biotronik)
September 25, 2020
Guidance Papers
Guidelines, consensus & position papers
August 28, 2020
Editorial
Steady-state hyperaemia
G.G. Toth
September 18, 2020
JAA
This Week's JAA's: Biograde Study, Advances in valvular heart interventions...
September 22, 2020
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke